Thousand Oaks-based Biotech giant Amgen announced a collaboration agreement with San Francisco software company Syapse, to develop precision medicine for cancer patients. In a news release May 2, the two companies said they plan to conduct research and use analytics to assess strategies for treating “areas of unmet need in oncology.” Syapse’s existing Learning Health…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
